ABSTRACT
Following a summer of severe drought and abnormally high temperatures, a major outbreak of EHDV occurred during 2012 in the USA. Although EHDV-1, -2 and -6 were isolated, EHDV-2 was the predominant virus serotype detected during the outbreak. In addition to large losses of white-tailed deer, the Midwest and northern Plains saw a significant amount of clinical disease in cattle. Phylogenetic analyses and sequence comparisons of newly sequenced whole genomes of 2012 EHDV-2 cattle isolates demonstrated that eight of ten EHDV-2 genomic segments show no genetic changes that separate the cattle outbreak sequences from other EHDV-2 isolates. Two segments, VP2 and VP6, did show several unique genetic changes specific to the 2012 cattle outbreak isolates, although the impact of the genetic changes on viral fitness is unknown. The placement of isolates from 2007 and 2011 as sister group to the outbreak isolates, and the similarity between cattle and deer isolates, point to environmental variables as having a greater influence on the severity of the 2012 EHDV outbreak than viral genetic changes.
Subject(s)
Cattle Diseases/virology , Hemorrhagic Disease Virus, Epizootic/genetics , Hemorrhagic Disease Virus, Epizootic/isolation & purification , Reoviridae Infections/veterinary , Animals , Cattle , Cattle Diseases/epidemiology , Deer/virology , Disease Outbreaks , Genetic Variation , Genome, Viral , Hemorrhagic Disease Virus, Epizootic/classification , Phylogeny , Reoviridae Infections/epidemiology , Reoviridae Infections/virology , United States/epidemiology , Viral Proteins/geneticsABSTRACT
Since 1999, 11 serotypes of bluetongue virus (BTV) similar to Central American or Caribbean strains have been isolated in the southeastern United States, predominantly in Florida. The majority of the incursive serotypes have remained restricted to the southeastern US. In recent years, BTV serotype 3 (BTV-3) has been isolated in areas increasingly distant from Florida. The current study uses whole genome sequencing of recent and historical BTV-3 isolates from the US, Central America and the Caribbean with additional sequences from GenBank to conduct phylogenetic analyses. The individual segments of the BTV genome were analysed to determine if recent BTV-3 isolates are reassortants containing genomic segments from endemic US serotypes or if they retain a majority of Central American/Caribbean genotypes. The analyses indicate that BTV-3 isolates Mississippi 2006, Arkansas 2008 and Mississippi 2009 are closely related reassortants that contain five to six genomic segments that are of US origin and two to three segments of Central American/Caribbean origin. In contrast, the BTV-3 South Dakota 2012 isolate contains seven genomic segments that are more similar to isolates from Central American and the Caribbean. These different evolutionary histories of the BTV-3 isolates suggest that there are at least two different lineages of BTV-3 that are currently circulating in the US.
Subject(s)
Bluetongue virus/genetics , Bluetongue/virology , Genome, Viral/genetics , Reassortant Viruses/genetics , Animals , Bluetongue/epidemiology , Bluetongue virus/immunology , Bluetongue virus/isolation & purification , Florida/epidemiology , Genotype , Phylogeny , Reassortant Viruses/immunology , Reassortant Viruses/isolation & purification , Serogroup , Sheep , Whole Genome Sequencing/veterinaryABSTRACT
Feline calicivirus (FCV) is a common cause of mild to severe upper respiratory tract disease (URTD) in cats. FCV strain 21223 was isolated from a kitten with severe pneumonia in a disease outbreak with unusually high mortality (35 %) that occurred in a Missouri feline colony in 1995-1996. Phylogenetic analysis of the genome sequence of strain 21223 indicated the emergence of a new FCV strain. Analysis of the full-length genome sequence of a closely related (99.5 % nucleotide identity) strain, 3786, obtained from an asymptomatic animal in the same colony four months later, showed the presence of seven amino acid substitutions, with six of them located in the VP1 capsid sequence encoded by ORF2. Comparative analysis of the E-region sequences (426-521 aa ORF2) presumably involved in virus-host cell receptor interactions did not identify amino acid substitutions unique to the virulent strain. We determined the complete genome sequences of four virus isolates that were collected in regional catteries in the months following the outbreak that were associated with different manifestations of the disease (URTD, chronic stomatitis, and gingivitis). We show that genetically distinct FCV strains were cocirculating in the area, and no apparent correlation could be made between overall sequence and observed disease.
Subject(s)
Caliciviridae Infections/veterinary , Calicivirus, Feline/classification , Calicivirus, Feline/genetics , Cat Diseases/pathology , Cat Diseases/virology , Animals , Asymptomatic Diseases , Caliciviridae Infections/pathology , Caliciviridae Infections/virology , Calicivirus, Feline/isolation & purification , Capsid Proteins/genetics , Cats , Cluster Analysis , Disease Outbreaks , Genome, Viral , Missouri/epidemiology , Molecular Sequence Data , Mutation, Missense , Phylogeny , RNA, Viral/genetics , Sequence Analysis, DNA , Sequence HomologyABSTRACT
BACKGROUND: It is universally acknowledged that genome segment 4 of group A rotavirus, the major etiologic agent of severe diarrhea in infants and neonatal farm animals, encodes outer capsid neutralization and protective antigen VP4. RESULTS: To determine which genome segment of three group A equine rotavirus strains (H-2, FI-14 and FI-23) with P[12] specificity encodes the VP4, we analyzed dsRNAs of strains H-2, FI-14 and FI-23 as well as their reassortants by polyacrylamide gel electrophoresis (PAGE) at varying concentrations of acrylamide. The relative position of the VP4 gene of the three equine P[12] strains varied (either genome segment 3 or 4) depending upon the concentration of acrylamide. The VP4 gene bearing P[3], P[4], P[6], P[7], P[8] or P[18] specificity did not exhibit this phenomenon when the PAGE running conditions were varied. CONCLUSIONS: The concentration of acrylamide in a PAGE gel affected VP4 gene coding assignment of equine rotavirus strains bearing P[12] specificity.
Subject(s)
Acrylamide/analysis , Capsid Proteins/analysis , RNA, Viral/analysis , Rotavirus/chemistry , Capsid Proteins/genetics , Capsid Proteins/metabolism , Electrophoresis, Polyacrylamide Gel , RNA, Viral/genetics , RNA, Viral/metabolism , Rotavirus/genetics , Rotavirus/metabolism , Species SpecificityABSTRACT
BACKGROUND: During the course of development and characterization of various rotavirus reassortants, we found that the relative position of the gene encoding neutralization and protective antigen VP7 of certain rotavirus strains in a PAGE gel was influenced by the concentration of acrylamide. OBJECTIVES: We investigated systematically various factors that affected the relative position of the rotavirus VP7 gene in a PAGE gel. STUDY DESIGN: We analyzed dsRNAs of selected rotavirus strains bearing G1, G2, G3 or G9 specificity by PAGE at varying concentrations of acrylamide. RESULTS: We demonstrated that the relative position of the VP7 gene of three G2 strains varied depending upon the concentration of acrylamide in a PAGE gel, which occurred not only in a homologous G2 virus gene background but also in a heterologous G3 virus gene background; and the VP7 gene bearing G1, G3, G4 or G9 specificity did not display this phenomenon when the PAGE running conditions were varied. CONCLUSIONS: The concentration of acrylamide in a PAGE gel was the major factor that influenced the relative position of the VP7 gene of G2 rotavirus strains (i.e., VP7 gene coding assignment by PAGE).
Subject(s)
Acrylamide/analysis , Acrylic Resins/chemistry , Antigens, Viral/genetics , Capsid Proteins/genetics , Electrophoresis, Polyacrylamide Gel/methods , RNA, Viral/isolation & purification , Rotavirus/genetics , Models, Molecular , Nucleic Acid Conformation , RNA, Double-Stranded/isolation & purification , Rotavirus/chemistryABSTRACT
In November 2004, tissues were collected from a hunter-killed white-tailed deer in St. Mary Parish, Louisiana. Bluetongue virus (BTV) was isolated from the tissues; however, the isolate could not be identified as any of the US domestic serotypes. Subsequent testing by virus neutralization using serotype-specific antiserum tentatively identified the isolate as BTV serotype 1 (BTV-1), which had not previously been found in the United States. Primers were designed based on the sequence of an outer capsid protein gene of a South African BTV-1 strain. Reverse transcription-polymerase chain reaction testing with the BTV-1 primers and product sequencing confirmed the Louisiana isolate as BTV-1. This is the first report of BTV-1 in the United States.
Subject(s)
Bluetongue virus/classification , Bluetongue virus/isolation & purification , Bluetongue/virology , Deer/virology , Animals , Bluetongue/diagnosis , Sheep , United StatesABSTRACT
Several mosquito-transmitted viruses are causative agents for zoonotic encephalomyelitis. Rapid identification of these viruses in mosquito populations is an effective method for surveying these diseases. To detect multiple mosquito-transmitted viral agents, including West Nile virus, Saint Louis encephalitis virus, Venezuelan equine encephalomyelitis virus, Western equine encephalomyelitis virus, Eastern equine encephalomyelitis virus, Highlands J virus and Japanese encephalitis virus, an assay using multiplex reverse-transcription PCR combined with microfluidic electrophoresis was developed and evaluated. Tailed nested primers were used in the assay to amplify specific viral genomic segments, and products with specific length were further analyzed by using a microfluidic electrophoresis chip. The assay exhibited good specificity and analytical sensitivity (10(2) copies/µL). This technology can be helpful in the quarantine and surveillance of exotic encephalomyelitis viruses which are transmitted by mosquitoes.
Subject(s)
Culicidae/virology , Electrophoresis, Microchip/veterinary , Encephalitis Viruses/isolation & purification , Epidemiological Monitoring/veterinary , Multiplex Polymerase Chain Reaction/veterinary , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Animals , Sequence Analysis, RNA/veterinaryABSTRACT
OBJECTIVE: To evaluate herd-level risk factors for seropositive status of cattle to 1 or more bluetongue viruses. ANIMALS: 110 herds of cattle in Nebraska, North Dakota, and South Dakota. PROCEDURE: Blood samples were collected before and after the vector season. Samples were tested for antibodies against bluetongue virus by use of a commercially available competitive ELISA. Factors evaluated included descriptors of geographic location and management practices. Trapping of insect vectors was conducted to evaluate vector status on a subset of 57 operations. A multivariable logistic regression model was constructed to evaluate associations. RESULTS: For the full data set, altitude and latitude were associated with risk of having seropositive cattle (an increase in altitude was associated with an increase in risk, and a more northerly location was associated with a decrease in risk of a premise having seropositive cattle). Import of cattle from selected states was associated with an increase in risk of having seropositive cattle. From the subset of herds with data on vector trapping, altitude and latitude were associated with risk of having seropositive cattle, similar to that for the full model. However, commingling with cattle from other herds was associated with a decrease in risk of seropositivity. CONCLUSIONS AND CLINICAL RELEVANCE: Findings reported here may be useful in generating additional hypotheses regarding the ecologic characteristics of bluetongue viruses and other vector-borne diseases of livestock. Sentinel surveillance programs are useful for documenting regionalization zones for diseases, which can be beneficial when securing international markets for animals and animal products.
Subject(s)
Bluetongue/epidemiology , Cattle Diseases/epidemiology , Animals , Antibodies, Viral/blood , Bluetongue virus/immunology , Cattle , Logistic Models , Nebraska/epidemiology , North Dakota/epidemiology , Odds Ratio , Prevalence , Risk Factors , Seroepidemiologic Studies , Sheep , South Dakota/epidemiologyABSTRACT
OBJECTIVE: To compare neutralizing antibody response between horses vaccinated against West Nile virus (WNV) and horses that survived naturally occurring infection. DESIGN: Cross-sectional observational study. ANIMALS: 187 horses vaccinated with a killed WNV vaccine and 37 horses with confirmed clinical WNV infection. PROCEDURE: Serum was collected from vaccinated horses prior to and 4 to 6 weeks after completion of an initial vaccination series (2 doses) and 5 to 7 months later. Serum was collected from affected horses 4 to 6 weeks after laboratory diagnosis of infection and 5 to 7 months after the first sample was obtained. The IgM capture ELISA, plaque reduction neutralization test (PRNT), and microtiter virus neutralization test were used. RESULTS: All affected horses had PRNT titers > or = 1:100 at 4 to 6 weeks after onset of disease, and 90% (18/20) maintained this titer for 5 to 7 months. After the second vaccination, 67% of vaccinated horses had PRNT titers > or = 1:100 and 14% had titers < 1:10. Five to 7 months later, 33% (28/84) of vaccinated horses had PRNT titers > or = 1:100, whereas 29% (24/84) had titers < 1:10. Vaccinated and clinically affected horses' end point titers had decreased by 5 to 7 months after vaccination. CONCLUSIONS AND CLINICAL RELEVANCE: A portion of horses vaccinated against WNV may respond poorly. Vaccination every 6 months may be indicated in certain horses and in areas of high vector activity. Other preventative methods such as mosquito control are warranted to prevent WNV infection in horses.
Subject(s)
Antibodies, Viral/biosynthesis , Horse Diseases/immunology , Horses/immunology , Viral Vaccines/immunology , West Nile Fever/veterinary , West Nile virus/immunology , Animals , Antibodies, Viral/blood , Cross-Sectional Studies , Culicidae/virology , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Horse Diseases/blood , Horse Diseases/prevention & control , Male , Mosquito Control , Neutralization Tests/veterinary , Viral Plaque Assay/veterinary , Viral Vaccines/administration & dosage , West Nile Fever/blood , West Nile Fever/immunology , West Nile Fever/prevention & controlABSTRACT
Bluetongue virus (BTV) is a vector-transmitted pathogen that typically infects and causes disease in domestic and wild ruminants. BTV is also known to infect domestic canines as discovered when dogs were vaccinated with a BTV-contaminated vaccine. Canine BTV infections have been documented through serological surveys, and natural infection by the Culicoides vector has been suggested. The report of isolation of BTV serotype 11 (BTV-11) from 2 separate domestic canine abortion cases in the states of Texas in 2011 and Kansas in 2012, were apparently unrelated to BTV-contaminated vaccination or consumption of BTV-contaminated raw meat as had been previously speculated. To elucidate the origin and relationship of these 2 domestic canine BTV-11 isolates, whole genome sequencing was performed. Six additional BTV-11 field isolates from Texas, Florida, and Washington, submitted for diagnostic investigation during 2011 and 2013, were also fully sequenced and analyzed. The phylogenetic analysis indicates that the BTV-11 domestic canine isolates are virtually identical, and both share high identity with 2 BTV-11 isolates identified from white-tailed deer in Texas in 2011. The results of the current study further support the hypothesis that a BTV-11 strain circulating in the Midwestern states could have been transmitted to the dogs by the infected Culicoides vector. Our study also expands the short list of available BTV-11 sequences, which may aid BTV surveillance and epidemiology.
Subject(s)
Bluetongue virus/isolation & purification , Bluetongue/epidemiology , Animals , Bluetongue/virology , Bluetongue virus/classification , Bluetongue virus/genetics , Camelids, New World , Deer , Disease Outbreaks/veterinary , Dogs , Phylogeny , Serogroup , United States/epidemiologyABSTRACT
This review provides an overview of current and potential new diagnostic tests for bluetongue (BT) and epizootic hemorrhagic disease (EHD) viruses compiled from international participants of the Orbivirus Gap Analysis Workshop, Diagnostic Group. The emphasis of this review is on diagnostic tools available to North American veterinary diagnosticians. Standard diagnostic tests are readily available for BT/EHD viruses, and there are described tests that are published in the World Organization for Animal Health (OIE) Terrestrial Manual. There is however considerable variation in the diagnostic approach to these viruses. Serological assays are well established, and many laboratories are experienced in running these assays. Numerous nucleic acid amplification assays are also available for BT virus (BTV) and EHD virus (EHDV). Although there is considerable experience with BTV reverse-transcriptase PCR (RT-PCR), there are no standards or comparisons of the protocols used by various state and federal veterinary diagnostic laboratories. Methods for genotyping BTV and EHDV isolates are available and are valuable tools for monitoring and analyzing circulating viruses. These methods include RT-PCR panels or arrays, RT-PCR and sequencing of specific genome segments, or the use of next-generation sequencing. In addition to enabling virus characterization, use of advanced molecular detection methods, including DNA microarrays and next-generation sequencing, significantly enhance the ability to detect unique virus strains that may arise through genetic drift, recombination, or viral genome segment reassortment, as well as incursions of new virus strains from other geographical areas.
Subject(s)
Bluetongue virus/isolation & purification , Bluetongue/diagnosis , Genotyping Techniques/veterinary , Hemorrhagic Disease Virus, Epizootic/isolation & purification , Reoviridae Infections/veterinary , Animals , Bluetongue virus/genetics , Bluetongue virus/immunology , Genotype , Hemorrhagic Disease Virus, Epizootic/genetics , Hemorrhagic Disease Virus, Epizootic/immunology , High-Throughput Nucleotide Sequencing/veterinary , North America , Reoviridae Infections/diagnosis , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA/veterinary , SheepABSTRACT
Recent Orbivirus occurrences in the Americas have been investigated using whole genome amplification and sequencing followed by phylogenetic analysis. The bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) whole genomes were amplified without prior sequence knowledge and deep sequenced. This technology was applied to evaluate BTV3 isolates spanning 4 decades from Florida, Arkansas, Mississippi, South Dakota, Central America, and the Caribbean basin. The results of the dataset analysis are consistent with the hypothesis that these viruses were introduced into the United States from Central America and the Caribbean basin. A similar analysis has been performed on a recent BTV2 isolate from California. It indicates that the BTV2 strain was likely introduced into Florida and then moved South to the Caribbean and West to California. A historical (19552012) molecular characterisation of EHDV strains was also completed, and subsequently used as reference sequence for comparison of genomes from recent 2012 cattle isolates associated with clinical disease. Finally, this analysis was performed on BTV11 isolated from 2 canine cases and demonstrated that the genome sequences of the virus isolates from these cases were almost identical. These studies indicate the value of this technology in understanding virus epidemiology and ecology.
Subject(s)
Bluetongue virus/genetics , Hemorrhagic Disease Virus, Epizootic/genetics , Americas , Animals , Bluetongue virus/classification , Cattle , Dogs , Evolution, Molecular , Hemorrhagic Disease Virus, Epizootic/classification , United StatesABSTRACT
Bovine sera from northeastern states (Connecticut, Delaware, Maine, Maryland, Massachusetts, New York, Pennsylvania, Vermont, and West Virginia), north central states (Indiana, Illinois, Iowa, Kentucky, Michigan, Minnesota, North Dakota, Ohio, South Dakota, and Wisconsin), Virginia, Alaska, and Hawaii were examined for the presence of neutralizing antibodies to Cache Valley (CV), Lokern (LK), Main Drain (MD), Northway (NW), and Tensaw (TS) viruses. Microneutralization tests were performed using Vero cells. Ninety percent inhibition of the virus at a 1:10 serum dilution was considered positive for the presence of specific antibody. Sera having antibody to more than one virus were titrated from 1:10 to 1:640. The results indicated that 4-28% of the cattle per region had specific antibodies to CV virus. Neutralizing antibodies to NW, LK, and TS viruses were also detected, indicating possible exposure to these Bunyamwera serogroup viruses along with CV virus. Antibody titers measured against NW virus were very similar to those against CV virus. Antibodies to MD virus were present in low levels in bovine sera from Illinois, Maryland, and Ohio. Cattle from Alaska had only antibodies to NW virus. Antibodies to Bunyamwera serogroup viruses were not observed in sera from Hawaii.
Subject(s)
Antibodies, Viral/blood , Antigens, Viral/immunology , Bunyaviridae/immunology , Animals , Antibodies, Viral/immunology , Cattle , Chlorocebus aethiops , Neutralization Tests , United States , Vero CellsABSTRACT
A traditional nested reverse transcription-polymerase chain reaction (RT-PCR) assay specific for eastern equine encephalomyelitis (EEE) virus was designed to multiplex with a previously described West Nile (WN) virus nested RT-PCR assay. Differentiation of EEE and WN was based on base pair size of the amplified product. One hundred fifty-seven mammalian and avian brain tissues were tested by EEE/WN nested multiplex RT-PCR, EEE nested RT-PCR, and WN nested RT-PCR, and results were compared with other diagnostic test results from the same animals. Serological and virus isolation testing confirmed the results of the multiplex PCR assay. When compared with cell culture virus isolation, the multiplex assay was shown to be more sensitive in detecting the presence of EEE or WN virus in brain tissues. The multiplex assay was shown to be sensitive and specific for North American EEE and WN and provided a rapid means of identifying both viruses in brain tissues. No apparent sacrifice in sensitivity was observed in the multiplex procedure compared with the individual EEE and WN nested RT-PCR assays. Data collected from an additional 485 multiplex RT-PCR tests conducted during the summer and fall of 2002 further support the validity of the procedure.
Subject(s)
Encephalomyelitis, Eastern Equine/veterinary , Horse Diseases/virology , West Nile Fever/veterinary , West Nile virus/isolation & purification , Animals , Base Sequence , DNA Primers , Diagnosis, Differential , Encephalomyelitis, Eastern Equine/diagnosis , Encephalomyelitis, Eastern Equine/virology , Horse Diseases/diagnosis , Horses , Polymerase Chain Reaction/methods , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Seasons , Sensitivity and Specificity , West Nile Fever/diagnosis , West Nile Fever/virologyABSTRACT
Many commercial antibody detection enzyme-linked immunosorbent assay (ELISA) kits for Q fever utilize the Nine Mile (Montana tick) strain of Coxiella burnetii as antigen. An ELISA kit manufactured in France employs ovine placenta-sourced antigen and has been used in Europe. Sera from goats experiencing a Q fever abortion storm in the United States were used to compare the sensitivity and specificity of these 2 ELISA formats and the Q fever complement fixation test (CFT). Latent class estimates of sensitivity ranged from 97% to 100% with a specificity of 95-100% for the 2 ELISA kits. Estimates for sensitivity and specificity of the CFT were 89% and 82%, respectively. There was not a significant increase in ELISA sensitivity observed with the ovine-sourced antigen kit in this study. Real-time polymerase chain reactions performed on a portion of the sera found that 15 out of 20 sera were congruent across 4 tests for positive and negative sera.
Subject(s)
Abortion, Veterinary/microbiology , Coxiella burnetii/isolation & purification , Disease Outbreaks/veterinary , Goat Diseases/microbiology , Q Fever/veterinary , Animals , Antibodies, Bacterial/blood , Complement Fixation Tests/veterinary , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Goat Diseases/blood , Goats , Polymerase Chain Reaction/veterinary , Pregnancy , Q Fever/blood , Q Fever/microbiology , Sensitivity and Specificity , United StatesABSTRACT
Bluetongue is a potentially fatal arboviral disease of domestic and wild ruminants that is characterized by widespread edema and tissue necrosis. Bluetongue virus (BTV) serotypes 10, 11, 13, and 17 occur throughout much of the United States, whereas serotype 2 (BTV-2) was previously only detected in the southeastern United States. Since 1998, 10 other BTV serotypes have also been isolated from ruminants in the southeastern United States. In 2010, BTV-2 was identified in California for the first time, and preliminary sequence analysis indicated that the virus isolate was closely related to BTV strains circulating in the southeastern United States. In the current study, the whole genome sequence of the California strain of BTV-2 was compared with those of other BTV-2 strains in the Americas. The results of the analysis suggest co-circulation of genetically distinct viruses in the southeastern United States, and further suggest that the 2010 western isolate is closely related to southeastern strains of BTV. Although it remains uncertain as to how this novel virus was translocated to California, the findings of the current study underscore the need for ongoing surveillance of this economically important livestock disease.
Subject(s)
Bluetongue virus/classification , Bluetongue/virology , Cattle Diseases/virology , Genome, Viral , Animals , Bluetongue virus/genetics , Bluetongue virus/isolation & purification , California , Cattle , Whole Genome Sequencing/veterinaryABSTRACT
Three aborted canine fetuses were submitted to the Animal Health Diagnostic Center at Cornell University in November 2011 and September 2012 for diagnostic workups to determine the causes of the reproductive difficulties. Histological assessments of the sampled tissues were inconclusive due to the autolysis. Tests to detect bacterial causes of the abortions were also negative. Virus isolation testing on pooled tissues from the fetuses identified a cytopathogenic agent in cell cultures. Fluorescent antibody tests on the infected cells gave a positive reaction for Bluetongue virus, and subsequent serotype specific reverse transcription polymerase chain reaction assays identified the isolates as Bluetongue virus serotype 11. The current report describes the isolation of Bluetongue virus from dogs unrelated to contaminated vaccines and in the absence of a raw meat diet.
Subject(s)
Aborted Fetus/virology , Bluetongue virus/isolation & purification , Bluetongue/virology , Dog Diseases/virology , Animals , Capsid Proteins/chemistry , Capsid Proteins/genetics , DNA, Viral/chemistry , DNA, Viral/genetics , Dogs , Enzyme-Linked Immunosorbent Assay/veterinary , Fatal Outcome , Female , Fluorescent Antibody Technique/veterinary , Neutralization Tests/veterinary , Pregnancy , Reverse Transcriptase Polymerase Chain Reaction/veterinaryABSTRACT
Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) possess similar structural and molecular features, are transmitted by biting midges (genus Culicoides), and cause similar diseases in some susceptible ruminants. Generally, BTV causes subclinical disease in cattle, characterized by a prolonged viremia. EHDV-associated disease in cattle is less prominent; however, it has emerged as a major economic threat to the white-tailed deer (Odocoileus virginianus) industry in many areas of the United States. The recent emergence of multiple BTV and EHDV serotypes previously undetected in the United States demonstrates the need for robust detection of all known serotypes and differential diagnosis. For this purpose, a streamlined workflow consisting of an automated nucleic acid purification and denaturation method and a multiplex one-step reverse transcription quantitative polymerase chain reaction for the simultaneous detection of BTV serotypes 1-24 and EHDV serotypes 1-7 was developed using previously published BTV and EHDV assays. The denaturation of double-stranded (ds) BTV and EHDV RNA was incorporated into the automated nucleic acid purification process thus eliminating the commonly used separate step of dsRNA denaturation. The performance of this workflow was compared with the World Organization of Animal Health BTV reference laboratory (National Veterinary Services Laboratory, Ames, Iowa) workflow for BTV and EHDV detection, and high agreement was observed. Implementation of the workflow in routine diagnostic testing enables the detection of, and differentiation between, BTV and EHDV, and coinfections in bovine blood and cervine tissues, offering significant benefits in terms of differential disease diagnosis, herd health monitoring, and regulated testing.
Subject(s)
Bluetongue virus/isolation & purification , Bluetongue/virology , Cattle Diseases/virology , Deer/virology , Hemorrhagic Disease Virus, Epizootic/isolation & purification , Reoviridae Infections/veterinary , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Animals , Bluetongue/diagnosis , Bluetongue virus/genetics , Cattle , Hemorrhagic Disease Virus, Epizootic/genetics , RNA, Viral/chemistry , RNA, Viral/genetics , Regression Analysis , Reoviridae Infections/diagnosis , Reoviridae Infections/virology , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction/methods , Sensitivity and Specificity , United StatesABSTRACT
Coxiella burnetii is an obligate intracellular bacterium that is responsible for the zoonotic disease Q fever. The distribution of this agent is worldwide except for New Zealand, and infection can be asymptomatic in both human beings and animals. Chronic exposures can produce abortions, stillbirths, and infertility issues in animals and endocarditis in human beings. A commercial enzyme-linked immunosorbent assay (ELISA) kit marketed in the European Union was purchased to compare C. burnetii antibody detection methods. The current study examined the agreement of ELISA and complement fixation results in over 668 diagnostic ruminant sera submitted to the National Veterinary Services Laboratories for Q fever serologic testing. The majority of combined sera (548) were negative on both tests. Fifty-seven of the combined sera were positive on both tests. There were 45 combined sera with low complement fixation titers at 1:10 and negative ELISA results. The results were surprising given the expectations that ELISA methods, by nature, amplify detection of antibody-antigen interactions leading to higher sensitivity. Potential mechanisms for these discrepant results are discussed.
Subject(s)
Cattle Diseases/microbiology , Coxiella burnetii/isolation & purification , Goat Diseases/microbiology , Q Fever/veterinary , Sheep Diseases/microbiology , Animals , Antibodies, Bacterial/blood , Cattle , Cattle Diseases/blood , Complement Fixation Tests/veterinary , Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/veterinary , Goat Diseases/blood , Goats , Q Fever/blood , Q Fever/microbiology , Sheep , Sheep Diseases/bloodABSTRACT
Semen from an apparently healthy 4-year-old American Quarter Horse was submitted to the National Veterinary Services Laboratories for Equine arteritis virus isolation. Visual inspection of the semen sample upon arrival noted it was unusually yellow in color. The semen sample was inoculated onto cell monolayers, and cytopathic effect was observed 5 days postinoculation. The resultant isolate tested negative for Equine arteritis virus, and was subsequently identified as Equine rhinitis A virus. Equine rhinitis A virus has been isolated from horse urine, but has not been described in stallion semen. The present study documents the isolation of Equine rhinitis A virus from stallion semen that was likely contaminated with urine at the time of collection.